申请人:Fundació Institut de Recerca Biomèdica
IRB (Barcelona)
公开号:EP3272880A2
公开(公告)日:2018-01-24
This study describes a method to determine the likelihood of the development of metastasis in a subject suffering from cancer, in addition to a method to design a customized therapy in a subject suffering from cancer, in particular breast, colon, lung, kidney and thyroid cancer, based on the determination of the expression level of one or more genes whose expression is modulated by an increase in c-MAF expression. It also describes a method for the identification of marker genes with a propensity for metastatic cancer based on inducing the modulation of the c-MAF expression Finally, the use of PTHLH and PODXL inhibitors and RERG activators in the treatment and/or prevention of the cancer, in particular breast, colon, lung, kidney and thyroid cancer.
本研究介绍了一种确定癌症患者发生转移的可能性的方法,以及一种为癌症患者(尤其是乳腺癌、结肠癌、肺癌、肾癌和甲状腺癌患者)设计定制疗法的方法,其依据是确定一个或多个基因的表达水平,这些基因的表达受 c-MAF 表达增加的调节。它还描述了一种基于诱导 c-MAF 表达调节来鉴定具有转移性癌症倾向的标记基因的方法。最后,还描述了 PTHLH 和 PODXL 抑制剂以及 RERG 激活剂在治疗和/或预防癌症(尤其是乳腺癌、结肠癌、肺癌、肾癌和甲状腺癌)中的应用。